Fertility and sterility

publication venue for

Euploid Programmed Frozen Embryo Transfer Cycles Are Associated with a Higher Live Birth Rate when Estradiol Levels More Closely Mimic Physiology. 2023
Successful Cryptozoospermia Management with Multiple Semen Specimen Collection. 2023
Semen parameter prediction of pregnancy. 2023
A prospective cohort study of infertility and cancer incidence. 2023
Male Haploid Cells Through Direct Spherification. 2023
ANTI-MÜLLERIAN HORMONE IS NOT ASSOCIATED WITH EMBRYO PLOIDY IN PATIENTS WITH AND WITHOUT INFERTILITY UNDERGOING IN VITRO FERTILIZATION WITH PREIMPLANTATION GENETIC TESTING. 2022
Pregnancy outcomes after oral and injectable ovulation induction in women with infertility with a low antimüllerian hormone level compared with those with a normal antimüllerian hormone level. 2022
Profiling the Male Germline Genome to Unravel its Reproductive Potential 2022
Comparative effectiveness of hysteroscopic and laparoscopic sterilization for women: a retrospective cohort study.. 117. 2022
Coronavirus disease 2019, reproductive health, and public policy: lessons learned after two years of the ongoing pandemic-the American Society for Reproductive Medicine's Center for Policy and Leadership. 2022
Characterization of an artificial intelligence model for ranking static images of blastocyst stage embryos. 2022
ASRM müllerian anomalies classification 2021.. 116. 2021
Testicular sperm characteristics in men with nonobstructive azoospermia and their impact on intracytoplasmic sperm injection outcome. 2021
One size does not fit all: variations by ethnicity in demographic characteristics of men seeking fertility treatment across North America. 2021
Is increasing paternal age negatively associated with donor oocyte recipient success? A paired analysis using sibling oocytes.. 116. 2021
Body mass index is not associated with embryo ploidy in patients undergoing in vitro fertilization with preimplantation genetic testing.. 116. 2021
Time from oocyte retrieval to frozen embryo transfer in the natural cycle does not impact reproductive or neonatal outcomes.. 115. 2021
Reproductive sequelae of parental severe illness before the pandemic: implications for the COVID-19 pandemic.. 114. 2020
Identification and treatment of men with phospholipase Cζ-defective spermatozoa.. 114. 2020
Cycle day 2 insulin-like growth factor-1 serum levels as a prognostic tool to predict controlled ovarian hyperstimulation outcomes in poor responders.. 113. 2020
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.. 113. 2020
No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019.. 113. 2020
Semen infections in men with primary infertility in the real-life setting.. 113. 2020
Vasovasostomy: kinetics and predictors of patency.. 113. 2020
Reprint of: Donor eggs: their application in modern reproductive technologies.. 112. 2019
Reprint of: High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction.. 112. 2019
Impact of right-left differences in ovarian morphology on the ultrasound diagnosis of polycystic ovary syndrome.. 112. 2019
Reproductive endocrinologists are the gatekeepers for male infertility care in North America: results of a North American survey on the referral patterns and characteristics of men presenting to male infertility specialists for infertility investigations.. 112. 2019
Impaired testicular signaling of vitamin A and vitamin K contributes to the aberrant composition of the extracellular matrix in idiopathic germ cell aplasia.. 111. 2019
BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.. 111. 2018
Changes in practice patterns in male infertility cases in the United States: the trend toward subspecialization.. 110. 2018
Blastocyst development rate influences implantation and live birth rates of similarly graded euploid blastocysts.. 110. 2018
Association between ABO blood type and live-birth outcomes in single-embryo transfer cycles.. 108. 2017
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.. 108. 2017
Vasectomy reversal semen analysis: new reference ranges predict pregnancy.. 107. 2017
Morphologic grading of euploid blastocysts influences implantation and ongoing pregnancy rates.. 107. 2017
Influence of increasing body mass index on semen and reproductive hormonal parameters in a multi-institutional cohort of subfertile men.. 106. 2016
Preimplantation genetic screening: who benefits?. 106. 2016
How low is too low? Cycle day 28 estradiol levels and pregnancy outcomes.. 105. 2015
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.. 105. 2015
Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes?. 105. 2015
Are pregnancy planning and timing associated with preterm or small for gestational age births?. 104. 2015
Higher pregnancy rates using testicular sperm in men with severe oligospermia.. 104. 2015
Three-dimensional sperm surface reconstruction: a novel approach to assessing sperm morphology.. 104. 2015
Elevated serum interleukin-1β levels and interleukin-1β-to-interleukin-1 receptor antagonist ratio 1 week after embryo transfer are associated with ectopic pregnancy.. 104. 2015
Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles.. 104. 2015
Outcomes of microdissection testicular sperm extraction in men with nonobstructive azoospermia due to maturation arrest.. 104. 2015
Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.. 104. 2015
Autologous endometrial coculture biopsy: is timing everything?. 104. 2015
Concordance among sperm deoxyribonucleic acid integrity assays and semen parameters.. 104. 2015
Fluorescence in situ hybridization detects increased sperm aneuploidy in men with recurrent pregnancy loss.. 103. 2015
Microdissection testicular sperm extraction in men with Sertoli cell-only testicular histology.. 102. 2014
Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia.. 103. 2014
Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?. 102. 2014
Integrative DNA methylation and gene expression analysis identifies discoidin domain receptor 1 association with idiopathic nonobstructive azoospermia.. 102. 2014
Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles.. 102. 2014
Raman spectroscopy as an ex vivo noninvasive approach to distinguish complete and incomplete spermatogenesis within human seminiferous tubules.. 102. 2014
Treatment of pelvic pain associated with endometriosis: a committee opinion.. 101. 2014
Simple circumcision device: proof of concept for a single-visit, adjustable device to facilitate safe adult male circumcision.. 101. 2014
Gonadal dysfunction in morbidly obese adolescent girls.. 101. 2014
Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.. 101. 2014
Knowledge, attitudes, and practices regarding conception and fertility: a population-based survey among reproductive-age United States women.. 101. 2014
Age does not adversely affect sperm retrieval in men undergoing microdissection testicular sperm extraction.. 101. 2014
Outcomes of operative sperm retrieval strategies for fertility preservation among males scheduled to undergo cancer treatment.. 101. 2014
WITHDRAWN: Initiation of the Society for Assisted Reproductive Technology Donor Egg Registry: a report from the Donor Egg Registry Task Force. 2013
Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor.. 100. 2013
Use of clomiphene citrate in infertile women: a committee opinion.. 100. 2013
Increased risk of cancer among azoospermic men.. 100. 2013
In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation?. 100. 2013
In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval.. 99. 2013
Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?. 99. 2013
Overweight men with nonobstructive azoospermia have worse pregnancy outcomes after microdissection testicular sperm extraction.. 99. 2012
Reducing multiples: a mathematical formula that accurately predicts rates of singletons, twins, and higher-order multiples in women undergoing in vitro fertilization.. 98. 2012
Vaccination guidelines for female infertility patients: a committee opinion.. 99. 2012
Using family members as gamete donors or surrogates.. 98. 2012
Human somatic cell nuclear transfer and cloning.. 98. 2012
Genetic variants in the ETV5 gene in fertile and infertile men with nonobstructive azoospermia associated with Sertoli cell-only syndrome.. 98. 2012
Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?. 98. 2012
Developmental potential of embryos from intracytoplasmic sperm injection cycles containing fragmented oocytes.. 97. 2011
Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells.. 96. 2011
Heat shock factor Y chromosome (HSFY) mRNA level predicts the presence of retrievable testicular sperm in men with nonobstructive azoospermia.. 96. 2011
Role of tissue digestion and extensive sperm search after microdissection testicular sperm extraction.. 96. 2011
Effect of time between human chorionic gonadotropin injection and egg retrieval is age dependent.. 95. 2011
Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study.. 95. 2011
Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide.. 95. 2010
A cross-sectional cohort study of infertile women awaiting oocyte donation: the emotional, sexual, and quality-of-life impact.. 95. 2010
Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle.. 95. 2010
Should all oocyte donors receive prophylactic antibiotics for retrieval?. 94. 2010
Racial variation in tubal sterilization rates: role of patient-level factors.. 95. 2010
Robotic versus standard laparoscopy for the treatment of endometriosis.. 94. 2010
Mayer-Rokitansky-Küster-Hauser syndrome: fertility counseling and treatment.. 94. 2010
A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia.. 94. 2009
Reproductive health of women electing bariatric surgery.. 94. 2009
Adverse effect of paroxetine on sperm.. 94. 2009
Incidence and development of zygotes exhibiting abnormal pronuclear disposition after identification of two pronuclei at the fertilization check.. 94. 2009
Human chorionic gonadotropin ratio of hemoperitoneum versus venous serum improves early diagnosis of ectopic pregnancy.. 93. 2008
High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction.. 92. 2008
A decision analysis of treatments for nonobstructive azoospermia associated with varicocele.. 92. 2008
Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates.. 90. 2008
Embryonic heart rate as a predictor of first-trimester pregnancy loss in infertility patients after in vitro fertilization.. 91. 2008
Advantage of conservative surgical management of large ovarian neoplasms in adolescents.. 91. 2008
Does vasectomy explain the difference in tubal sterilization rates between black and white women?. 91. 2008
The incidence of both serious and minor complications in young women undergoing oocyte donation.. 90. 2008
Race, insurance status, and desire for tubal sterilization reversal.. 90. 2007
Researching human oocyte cryopreservation: ethical issues.. 89. 2007
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome.. 88. 2007
Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes.. 87. 2007
New methods for deriving embryonic stem cell lines: are the ethical problems solved?. 86. 2006
Immunohistochemical expression of endometrial L-selectin ligand is higher in donor egg recipients with embryonic implantation.. 86. 2006
Predictors of embryo fragmentation and outcome after fragment removal in in vitro fertilization.. 86. 2006
Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome.. 86. 2006
Correlation of ultrasound-measured venous size and reversal of flow with Valsalva with improvement in semen-analysis parameters after varicocelectomy.. 86. 2006
Mouse ascites Golgi mucin expression abnormalities in natural cycle endometrial biopsies predict subsequent in vitro fertilization-embryo transfer (IVF-ET) failure in patients with previous IVF-ET failures.. 85. 2006
Management of patients receiving long-term treatment with mifepristone.. 84. 2005
Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders.. 84. 2005
Screening the SPO11 and EIF5A2 genes in a population of infertile men.. 84. 2005
A multicenter study evaluating the flowcytometric-based kit for semen analysis.. 83. 2005
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories.. 83. 2005
Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization.. 83. 2005
Protein expression profiling of endometriosis: validation of 2-mm tissue microarrays.. 82. 2004
High pregnancy rates can be achieved after freezing and thawing human blastocysts.. 82. 2004
Sperm cryopreservation and in vitro fertilization/intracytoplasmic sperm injection in men with congenital bilateral absence of the vas deferens: a success story.. 82. 2004
Pregnancy outcome of in vitro fertilization/intracytoplasmic sperm injection with profound teratospermia.. 82. 2004
Microsurgical treatment of persistent or recurrent varicocele.. 82. 2004
Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report.. 82. 2004
Maternal serum vascular endothelial growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment.. 82. 2004
Role of varicocelectomy in men with nonobstructive azoospermia.. 81. 2004
Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss.. 81. 2004
Superior outcomes of microsurgical vasectomy reversal in men with the same female partners.. 81. 2004
AZF microdeletions of the Y chromosome and in vitro fertilization outcome.. 81. 2004
In vitro transfection of the human vas deferens using DNA-liposome and DNA-neutral lipid complexes.. 81. 2004
Relationship between semen cultures, leukospermia, and semen analysis in men undergoing fertility evaluation.. 79 Suppl 3. 2003
Cryopreservation of nuclear material as a potential method of fertility preservation.. 79. 2003
Focused ultrasound ablation of the epididymis with use of thermal measurements in a canine model.. 78. 2002
Importance of the biopsy date in autologous endometrial cocultures for patients with multiple implantation failures.. 77. 2002
In vitro culture and in vitro maturation of mouse preantral follicles with recombinant gonadotropins.. 77. 2002
Application of complementary DNA microarray (DNA chip) technology in the study of gene expression profiles during folliculogenesis.. 75. 2001
Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility.. 75. 2001
Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.. 75. 2001
Use of electively cryopreserved microsurgically aspirated epididymal sperm with IVF and intracytoplasmic sperm injection for obstructive azoospermia.. 74. 2000
Shared oocyte donation: society's benefits.. 73. 2000
Use of frozen-thawed testicular sperm for intracytoplasmic sperm injection.. 73. 2000
Human sperm microinjection into hamster oocytes: a new tool for training and evaluation of the technical proficiency of intracytoplasmic sperm injection.. 73. 2000
Are cytokines and growth factors responsible for the detrimental effects of hydrosalpingeal fluid on pregnancy rates after in vitro fertilization-embryo transfer?. 72. 1999
Recycling of a single human blastomere fixed on a microscopic slide for sexing and diagnosis of specific mutations by various types of polymerase chain reaction.. 72. 1999
Incidence of sperm aneuploidy in relation to semen characteristics and assisted reproductive outcome.. 72. 1999
Fertilization after standard in vitro fertilization versus intracytoplasmic sperm injection in subfertile males using sibling oocytes.. 71. 1999
The embryo toxicity of hydrosalpinx fluid is only apparent at high concentrations: an in vitro model that stimulates in vivo events.. 71. 1999
Human endometrial stromal cells improve embryo quality by enhancing the expression of insulin-like growth factors and their receptors in cocultured human preimplantation embryos.. 71. 1999
Oocyte donation: insights into implantation.. 71. 1999
Human preembryo development on autologous endometrial coculture versus conventional medium.. 70. 1998
Human sperm endothelial nitric oxide synthase expression: correlation with sperm motility.. 70. 1998
Oocyte donation: does a previous attempt affect a subsequent attempt?. 70. 1998
Induction of spermatogenesis and achievement of pregnancy after microsurgical varicocelectomy in men with azoospermia and severe oligoasthenospermia.. 70. 1998
Reliability of intraobserver and interobserver sonographic endometrial stripe thickness measurements.. 70. 1998
Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone.. 69. 1998
Absence of cyclic adenosine 3':5' monophosphate responsive element modulator expression at the spermatocyte arrest stage.. 69. 1998
Delay of gonadotropin stimulation in patients receiving gonadotropin-releasing hormone agonist (GnRH-a) therapy permits increased clinic efficiency and may enhance in vitro fertilization (IVF) pregnancy rates.. 68. 1997
In situ end-labeling of human testicular tissue demonstrates increased apoptosis in conditions of abnormal spermatogenesis.. 68. 1997
Expression of glutathione peroxidases in the adult male rat reproductive tract.. 68. 1997
Postoperative day 1 serum human chorionic gonadotropin level as a predictor of persistent ectopic pregnancy after conservative surgical management.. 68. 1997
Simultaneous detection of multiple gene expression in mouse and human individual preimplantation embryos.. 67. 1997
Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.. 67. 1997
Correlation between semen parameters of electroejaculates and achieving pregnancy by intrauterine insemination.. 67. 1997
Fertility options after vasectomy: a cost-effectiveness analysis.. 67. 1997
Endometrial stripe thickness as a predictor of ectopic pregnancy.. 66. 1996
Aneuploidy 16 in human embryos increases significantly with maternal age.. 66. 1996
Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization.. 64. 1995
A quality control system for the optimized sperm penetration assay.. 64. 1995
Cystic fibrosis gene mutations do not affect sperm function during in vitro fertilization with micromanipulation for men with bilateral congenital absence of vas deferens.. 64. 1995
Endometriosis: a stage by stage analysis--the role of in vitro fertilization.. 64. 1995
Intracytoplasmic sperm injection: a novel treatment for all forms of male factor infertility.. 63. 1995
Epididymal micropuncture with in vitro fertilization and oocyte micromanipulation for the treatment of unreconstructable obstructive azoospermia.. 61. 1994
Assisted hatching facilitates earlier implantation.. 60. 1993
A neural network to analyze fertility data.. 60. 1993
Tests of sperm function for evaluation of the male: Penetrak and Tru-Trax.. 60. 1993
A novel technique for cervical cannulation during hysterosalpingography.. 59. 1993
Assisted reproductive technology in the United States and Canada: 1991 results from the Society for Assisted Reproductive Technology generated from the American Fertility Society Registry.. 59. 1993
Response to intermittent RU486 in women.. 59. 1993
Sperm characteristics and outcome of human assisted fertilization by subzonal insemination and intracytoplasmic sperm injection.. 59. 1993
Loss of fertility in men with varicocele.. 59. 1993
Interinstitutional variability of follicle-stimulating hormone and estradiol levels.. 58. 1992
Sperm acrosin activity and fluorescence microscopic assessment of proacrosin/acrosin in ejaculates of infertile and fertile men.. 57. 1992
Partial zona dissection or subzonal sperm insertion: microsurgical fertilization alternatives based on evaluation of sperm and embryo morphology.. 56. 1991
A human in vivo model for the luteoplacental shift.. 56. 1991
Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.. 56. 1991
Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys.. 55. 1991
The window of embryo transfer and the efficiency of human conception in vitro.. 55. 1991
Changes in gonadotropin and alpha-subunit secretion after a single administration of gonadotropin-releasing hormone antagonist in adult males.. 53. 1990
Surgical treatment of symptomatic colorectal endometriosis.. 53. 1990
Circulating interferon-gamma in women sensitized to sperm: new mechanisms of infertility.. 52. 1989
Estradiol and progesterone replacement regimens for the induction of endometrial receptivity.. 52. 1989
Assisted procreation in the presence of a positive direct mixed antiglobulin reaction test.. 52. 1989
Correlation of sperm-bound immunoglobulins with impaired semen analysis in infertile men with varicoceles.. 52. 1989
Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.. 51. 1989
The incidence of luteal phase defect in normal, fertile women, determined by serial endometrial biopsies.. 51. 1989
Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.. 51. 1989
Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transfer.. 51. 1989
Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.. 50. 1988
Implantation potential of each pre-embryo in multiple pregnancies obtained by in vitro fertilization seems to be different.. 50. 1988
Transdermal estrogen replacement in ovarian failure for ovum donation.. 50. 1988
Distribution of T cell subsets in follicular fluid.. 50. 1988
Production of interferon gamma by lymphocytes exposed to antibody-coated spermatozoa: a mechanism for sperm antibody production in females.. 50. 1988
Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program.. 50. 1988
Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities.. 50. 1988
The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.. 50. 1988
Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients.. 50. 1988
Mechanisms and factors of early pregnancy wastage in in vitro fertilization-embryo transfer patients.. 50. 1988
A preclinical evaluation of pronuclear formation by microinjection of human spermatozoa into human oocytes.. 49. 1988
The value of in vitro fertilization for the treatment of unexplained infertility.. 49. 1988
Partial characterization of a unique growth factor secreted by human Sertoli cells.. 49. 1988
The efficiency of human reproduction after in vitro fertilization and embryo transfer.. 49. 1988
The hemizona assay (HZA): development of a diagnostic test for the binding of human spermatozoa to the human hemizona pellucida to predict fertilization potential.. 49. 1988
Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles.. 49. 1988
Follicular fluid estradiol and progesterone are markers of preovulatory oocyte quality.. 48. 1987
Results of in vitro fertilization attempts in patients with one or two ovaries.. 47. 1987
Results of in vitro fertilization attempts in women 40 years of age and older: the Norfolk experience.. 47. 1987
The perimenopausal patient in in vitro fertilization: the use of gonadotropin-releasing hormone.. 46. 1986
The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.. 44. 1985
The role of in vitro fertilization in infertile patients with endometriosis.. 44. 1985
The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women.. 43. 1985
The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.. 43. 1985
Three years of in vitro fertilization at Norfolk.. 42. 1984
Wedge metroplasty for the septate uterus: an update.. 42. 1984
Detection and characterization of immune complexes in the circulation of infertile women.. 42. 1984
The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial.. 42. 1984
Relationship between genital tract infections, sperm antibodies in seminal fluid, and infertility.. 40. 1983
Vasectomy failure using an open-ended technique.. 40. 1983
Immune responses to spermatozoa in homosexual men.. 39. 1983
Structure and function of the fallopian tubes following exposure to diethylstilbestrol (DES) during gestation.. 36. 1981
Exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide in primary testicular failure.. 34. 1980
Effects of vasectomy and antisperm antibodies on human seminal fluid deoxyribonucleic acid polymerase activity.. 29. 1978
Isolated hypogonadotropic hypogonadism: induction of ovulation with exogenous gonadotropins.. 28. 1977
Male infertility biomarkers and genomic aberrations in azoospermia.. 101. 2014
Reply of the authors.. 101. 2014
Microdissection testicular sperm extraction in older men.. 101. 2014
Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor.. 100. 2013
Increased cancer risk and azoospermia.. 100. 2013
Reply of the authors.. 99. 2013
Ethical issues surrounding the cryopreservation of human oocytes.. 88. 2007
IVF and HPV.. 87. 2007
The intangible female factor affecting the success of vasovasostomy?. 83. 2005
Viability of sperm without tails?. 83. 2005
The generalizability of antiphospholipid testing?. 74. 2000
Testing for Chlamydia antibodies in recurrent spontaneous abortion.. 73. 2000
The role of hydrosalpinx in IVF: are we getting closer to an answer?. 72. 1999
The first hope for the "big picture" of infection--DNA microarrays.. 72. 1999
Sensitivity specificity and likelihood ratios--do they deserve confidence intervals?. 70. 1998
Numbers of embryos transferred or other factors?. 69. 1998
Has traditional sperm analysis lost its clinical relevance?. 67. 1997
The disappearing Y chromosome--"I told you so!".. 67. 1997
Would Chlamydia trachomatis recombinant ribonucleic acid be a better target for identification?. 65. 1996
Antisperm antibodies and recurrent abortion.. 60. 1993
Silent infection with Chlamydia--significance.. 57. 1992
Hamster testing and egg yolk.. 55. 1991
Sperm Production is Stable Over Time for Men with Azoospermia Factor C (AZFc) Y-Chromosome Microdeletions. 2023
United States vasectomy incidence rises following the reversal of Roe v. Wade in a national clinical and claims database. 2023
Reply of the Authors: Testicular sperm characteristics in men with nonobstructive azoospermia and their impact on intracytoplasmic sperm injection outcome. 2022
The playing field is changing…. 2014
Reporting of clinical outcomes in assisted reproductive technology. 2013
The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. 2010
Reply of the Authors: Embryonic heart rates. 2009
Intracytoplasmic sperm injection is still the best management of male factor infertility.. 121. 2024
Intracytoplasmic sperm injection revisited: ideal intervention or purveyor of disease?. 121. 2024
Educational aid for penile vibratory stimulation.. 121. 2024
Day7 and low-quality blastocysts: opt in or opt out? A dilemma with important clinical implications.. 120. 2023
We are giving the wrong patient instructions for semen analysis before ART. 2023
Commentary: "No Where to Hide… From Endocrine Disrupting Chemical Exposures". 2023
Cervical agenesis: surgical preservation of reproductive potential in spite of anatomic variation.. 118. 2022
The timing of frozen embryo transfer-is there such a thing as too early or too late? 2022
Should preimplantation genetic testing for polygenic disease be offered to all - or none? 2022
Depression and semen quality. 2021
Are worldwide sperm counts declining?. 116. 2021
Sperm DNA fragmentation: What have we learned so far? 2021
Media regurgitation after intrauterine insemination: Is the uterus half empty or half full? 2021
A message From the Media Editors of the Fertility and Sterility family of journals. 2021
Iconic brands: standing the test of time with a little rebranding.. 116. 2021
Surgical innovation begins at the end of your comfort zone.. 116. 2021
Human embryo genetic editing: hope or pipe dream?. 116. 2021
In grateful recognition of departing Editors-in-Chief Craig Niederberger and Antonio Pellicer.. 115. 2021
Sperm DNA fragmentation: a need to fully address the impact on fertility outcomes.. 116. 2021
Postwash total motile sperm count and intrauterine insemination pregnancy rate: how low can you go?. 115. 2021
Reproductive Endocrinology and Infertility fellowship programs: Does one size fit all?. 115. 2021
Training the next generation of reproductive endocrinology and infertility subspecialists.. 115. 2021
The importance of microdissection testicular sperm extraction intervention after prior failed nonobstructive azoospermia treatment.. 115. 2021
Lessons from the tortoise and the hare.. 115. 2021
Mayer-Rokitansky-Küster-Hauser syndrome associated with fused renal ectopia and hydroureter.. 115. 2021
"Online" and "at-home" versus traditional models of health care: enhancing access or impeding optimal therapeutics?. 114. 2020
Wonderfully wild müllerian anomalies.. 114. 2020
Primum non nocere: in vitro fertilization in the epicenter.. 114. 2020
Growth hormone: in search of the Holy Grail for poor responders (or a felony).. 114. 2020
Creating a national database that is inclusive of all infertility therapies: a notion whose time has come.. 113. 2020
Immunologic and rheumatologic aspects of recurrent pregnancy loss: have the sirens enchanted us onto the rocks?. 112. 2019
Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence?. 112. 2019
Preimplantation genetic testing for aneuploidy: It's déjà vu all over again!. 112. 2019
25 historic papers: an ASRM 75th birthday gift from Fertility and Sterility.. 112. 2019
Artificial intelligence: its applications in reproductive medicine and the assisted reproductive technologies.. 112. 2019
When to jump-start fertilization.. 112. 2019
Evolving insights into the relationship between miR-23a/b-3p and target genes in subfertile patients.. 112. 2019
DNA methylation profiling of peripheral blood samples is a promising new approach to screen for male infertility.. 112. 2019
Universal assisted reproductive technology coverage: a worthy cause that promotes safety.. 110. 2018
Egg donation model: an excellent way to isolate and analyze the impact of the male partner on assisted reproductive technology outcome.. 110. 2018
Pros and cons of robotic microsurgery as an appropriate approach to male reproductive surgery for vasectomy reversal and varicocele repair.. 110. 2018
Programmed versus natural frozen embryo transfer: which is the best nest?. 110. 2018
Is preimplantation genetic testing for aneuploidy an essential tool for embryo selection or a costly 'add-on' of no clinical benefit?. 110. 2018
The pros and cons of preimplantation genetic testing for aneuploidy: clinical and laboratory perspectives.. 110. 2018
Use of testicular sperm in nonazoospermic males.. 109. 2018
Time-lapse imaging: clearly useful to both laboratory personnel and patient outcomes versus just because we can doesn't mean we should.. 109. 2018
Chromosomal mosaicism in human preimplantation embryos: another fact that cannot be ignored.. 109. 2018
A fresh(er) perspective on frozen embryo transfers.. 106. 2016
Searching for the perfect child.. 103. 2015
Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population.. 90. 2008
Ovarian tissue cryopreservation: the time is now. Transplantation or in vitro maturation: the time awaits.. 69. 1998
Implications of the Fertility Clinic Success Rate and Certification Act of 1992.. 59. 1993
In vitro fertilization and andrology laboratory in 2030: expert visions. 2021
The impact of SARS-CoV-2 and COVID-19 on male reproduction and men's health. 2021
Clinical implications of telemedicine for providers and patients. 2020
Artificial intelligence in human in vitro fertilization and embryology. 2020
Precision medicine and artificial intelligence: overview and relevance to reproductive medicine. 2020
Predictive modeling in reproductive medicine: Where will the future of artificial intelligence research take us? 2020
Male infertility and genitourinary birth defects: there is more than meets the eye. 2020
Where are we going with gene screening for male infertility? 2019
Microsurgical vasectomy reversal: contemporary techniques, intraoperative decision making, and surgical training for the next generation. 2019
Fertility in patients with nonclassical congenital adrenal hyperplasia. 2019
Oocyte donation: insights gleaned and future challenges. 2018
Forty years of IVF. 2018
Development of in vitro fertilization in the United States: a conversation between Zev Rosenwaks and Jairo E. Garcia. 2018
p53 and reproduction. 2018
Assessment of embryo morphology and developmental dynamics by time-lapse microscopy: is there a relation to implantation and ploidy? 2017
Age-related alterations in the genetics and genomics of the male germ line. 2017
Role of the mental health professional in education and support of the medical staff. 2015
Male biological clock: a critical analysis of advanced paternal age. 2015
Perspectives on the assessment of human sperm chromatin integrity. 2014
The effect of 5α-reductase-2 deficiency on human fertility. 2014
Fertility in patients with congenital adrenal hyperplasia. 2013
A psychological perspective on male rejuvenation. 2013
Aromatase inhibitors for male infertility. 2012
Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. 2012
Development and current applications of assisted fertilization. 2012
Role of acupuncture in the treatment of female infertility. 2002
Intracytoplasmic sperm injection: a powerful tool to overcome fertilization failure. 1996
Assisted fertility using electroejaculation in men with spinal cord injury--a review of literature. 1995
Antibiotics: potential hazards to male fertility. 1991
Can sperm quality affect reproductive outcomes? 2023
SPERM CENTRIOLAR FACTORS AND GENETIC DEFECTS THAT CAN PREDICT PREGNANCY. 2023
Reproductive Surgery: Revisiting Its Origins and Role in the Modern Management of Fertility. 2023
What advances may the future bring to the diagnosis, treatment, and care of male sexual and reproductive health? 2022
Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. 2014

VIVO Weill Cornell Medical College

Fertility and sterility Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)